Taiji Sekigami
Yatsushiro, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Reduction in hsCRP levels is associated with decreased incidence of cardiovascular events in Japanese hypertensive women but not in men.
Journal: Scientific reports
Published: June 05, 2020
Total adiponectin is associated with incident cardiovascular and renal events in treated hypertensive patients: subanalysis of the ATTEMPT-CVD randomized trial.
Journal: Scientific reports
Published: July 19, 2019
Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes: a pilot, randomized, controlled study.
Journal: Endocrine journal
Published: July 17, 2019
Anemia is an independent risk factor for cardiovascular and renal events in hypertensive outpatients with well-controlled blood pressure: a subgroup analysis of the ATTEMPT-CVD randomized trial.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: June 29, 2018
Cardiovascular and renal protective role of angiotensin blockade in hypertension with advanced CKD: a subgroup analysis of ATTEMPT-CVD randomized trial.
Journal: Scientific reports
Published: September 27, 2017
A 1-year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal-bolus insulin therapy (Kumamoto Insulin Degludec Observational study).
Journal: Journal of diabetes investigation
Published: October 09, 2015
A trial of telmisartan prevention of cardiovascular diseases (ATTEMPT-CVD): Biomarker study.
Journal: European journal of preventive cardiology
Published: July 10, 2015
Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy.
Journal: Endocrine journal
Published: November 14, 2014
Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy.
Journal: Endocrine journal
Published: August 06, 2013
Comparison of the efficacy of sitagliptin and glimepiride dose-up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination.
Journal: Journal of diabetes investigation
Published: April 19, 2013
Ezetimibe improves glucose metabolism by ameliorating hepatic function in Japanese patients with type 2 diabetes.
Journal: Journal of diabetes investigation
Published: March 28, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026